Using facial analysis technology we compared 246 individuals with CdLS to 246 gender/age matched controls and found that sensitivity was equal or greater than 95% for all groups.
Specificity was equal or greater than 91%. In conclusion, we present consistent clinical findings from global populations with CdLS while demonstrating how facial analysis technology can be a tool to support accurate diagnoses in the clinical setting. This work, along with prior studies in this arena, will assist in earlier detection, recognition, and treatment of CdLS worldwide. (Mannini, Cucco, Quarantotti, Krantz, & Musio, 2013) . The characteristic facial dysmorphisms, critical in establishing a clinical diagnosis, include microcephaly, arched eyebrows, synophrys, short nose with depressed bridge and anteverted nares, long philtrum, thin vermillion of the upper lip, micrognathia, and hypertrichosis. While wide phenotypic variability exists within the CdLS spectrum, ranging from mild to severe, most patients have growth deficiency, intellectual disability, and facial dysmorphism Mehta et al., 2016) . There are five identified genes known to cause CdLS when mutated-NIPBL, SMC1A, HDAC8, SMC3, and RAD21 . Because there is variability between clinical presentation based on causative gene and mutation type, evaluating the CdLS phenotype in patients of diverse descent or mixed-ancestry can make diagnosis difficult. Early diagnosis of CdLS is imperative to address life threatening medical issues such as malrotation and seizures (Deardorff, Noon, & Krantz, 2016; .
CdLS is a well-recognized condition; however, clinical descriptions of patients with CdLS from diverse ancestral backgrounds in the available medical literature are limited. There are a few case reports with African, Korean, Indian, Iranian, and Malaysian individuals with CdLS (Familant, 1968; Kim, Park, & Choi, 2005; Bhuiyan, Zilfalil, & Hennekam, 2006; Badoe, 2006; Reddy, Neelaveni, & Kumar, 2013; Shenoy, Gupta, Sachdeva, & Kekunnaya, 2014; Tayebi, 2017) . There are, however, numerous case reports of Caucasian individuals (DeScipio et al., 2005; Russell et al., 2001) . Larger studies have come out of Europe including patients from Italy, Canada, the United Kingdom, and the United States of America (Musio et al., 2006; Kline, Grados, et al., 2007; Olioso et al., 2009; Rohatgi et al., 2010; Deardorff et al., 2012; Pehlivan et al., 2012; Huisman et al., 2017) .
Very few publications have focused on diverse populations such as Africans, Asians, and Latin Americans. As a result, many clinicians are trained with clinical genetic resources where only patients of European descent serve as the standard of reference (Muenke, Adeyemo, & Kruszka, 2016 
| Patients
We evaluated the dysmorphologic features in a large cohort of individuals with a clinical diagnosis of CdLS, and limited our analyses to patients with both clinical diagnoses and available clinical images. The average age was 4.2 years (range from birth to 37 years), the median age was 3 years, and 49% were females (Supporting Information   Table S1 ). We evaluated individuals with CdLS from 15 countries and identified 246 individuals belonging to the following ancestry groups-Caucasian (n = 183), African and African American (n = 14), Asian (n = 23), Latin American (n = 22), and Middle Eastern (n = 8).
These groupings were made based on self-identification, with the understanding that phenotypes may vary considerably even within the same ancestry group. All patients had been consented and evaluated by a trained clinical geneticist for features consistent with a diagnosis of CdLS, many of whom also had confirmed molecular diagnoses. Exam findings from our current study and those from the medical literature are recorded for review (Table 1) .
| Facial analysis technology
As described previously , digital facial analysis technology was used to evaluate the frontal photos of individuals with CdLS from underrepresented minority backgrounds in our study (Cerrolaza et al., 2016; Zhao et al., 2013; . Both the underrepresented minority patients in our study and Caucasian controls with CdLS were matched by age and gender to unaffected individuals. The distribution of the dataset is presented in Table 2 .
Using only facial images of our study participants, analysis was performed with our algorithms. Output consisted of feature extraction, selection, and classification. As in our previous studies, after facial detection and landmark positioning, a set of 126 facial features were extracted from a set of 44 landmarks placed on the frontal face images. This included both geometric and texture biomarkers. The geometric biomarkers consisted of a set of distances and angles calculated between the different inner facial landmarks as represented in Figure 1 . As markers of monotonic illumination changes, local binary patterns were calculated at each of the 33 inner facial landmarks to quantify texture information. From the collection of geometric and texture features, those with the most significance were selected by methods previously described (Cai, Zhang, & He, 2010) . For each feature set, a support vector machine classifier (Cortes & Vapnik, 1995) was trained using a leave-one-out strategy cross-validation (Elisseeff & Pontil, 2003) . The optimal number of features was selected as the one which maximized the classification of accuracy.
Supporting Information Figures S1-S5 graphically demonstrate how the addition of features improves sensitivity, specificity, and accuracy within each ancestry group. Additionally, as an estimator of the individual discriminant power of each selected feature, the significance (p-value) was estimated using the Student's t test. Significance between methods used to detect CdLS was assessed using the Fisher's exact test. respectively. Figure 6 shows an age progression in some of the patients. Table 1 was identified in 40% of the patients in our study-which falls within expected reports based on prior characterization studies ranging from 14 to 70% (Chatfield et al., 2012) .
For many patients with NIPBL mutations, the severity of their features makes their clinical diagnosis easily recognizable. However, we do know that there are more subtle features appreciable depending on gene involved and mutation type (Figures 2-6 ), and this diagnosis can potentially be missed (Deardorff, Krantz, & Shirahige, 2013; Gillis et al., 2004; Gil-Rodríguez et al., 2015) . Facial analysis technology can complement the elements of dysmorphologic examination, especially where molecular diagnosis may not be readily available. The study showed that the technology was able to diagnose patients from all ancestry groups with a sensitivity of 95% and a specificity of 93%.
When evaluating within ancestry groups by the facial analysis algorithm, sensitivity and accuracy both increased to greater than or equal to 95% for all groups (Table 3) . The technology identified quantitative facial biometrics specific to CdLS for each ancestry group. As expected, the analysis found lip width, distance between nose root and apex, and distance between medial canthi as significant features in all population groups (Supporting Information Tables S2-S6 ).
Though molecular technologies are becoming more widespread and readily available, they are not as ubiquitous as the internet and accepted patients for inclusion in this study that were diagnosed clinically by a trained medical geneticist. The majority of our cohort, greater than 90%, had confirmed molecular diagnoses.
We understand that while ancestral subpopulations are unique, grouping individuals into broad categories is arbitrary. We also acknowledge that racial admixture exists across global populations as well. Future studies will allow us to account for genotype-phenotype Kruszka, Addissie, McGinn, et al., 2017; Kruszka, Porras, Sobering, et al., 2017) , we predict that digital facial analysis technologies have applicability to individuals from widespread and diverse ancestral backgrounds-for both CdLS and other syndromes with distinct and recognizable dysmorphology.
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